These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26259542)

  • 1. Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infants.
    Blakney AK; Tchakoute CT; Hesseling AC; Kidzeru EB; Jones CE; Passmore JA; Sodora DL; Gray CM; Jaspan HB
    Vaccine; 2015 Sep; 33(38):4782-9. PubMed ID: 26259542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.
    Kidzeru EB; Hesseling AC; Passmore JA; Myer L; Gamieldien H; Tchakoute CT; Gray CM; Sodora DL; Jaspan HB
    AIDS; 2014 Jun; 28(10):1421-30. PubMed ID: 24785950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
    Hesseling AC; Blakney AK; Jones CE; Esser MM; de Beer C; Kuhn L; Cotton MF; Jaspan HB
    Vaccine; 2016 Jul; 34(32):3702-9. PubMed ID: 27055019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.
    Tchakoute CT; Hesseling AC; Kidzeru EB; Gamieldien H; Passmore JA; Jones CE; Gray CM; Sodora DL; Jaspan HB
    J Infect Dis; 2015 Feb; 211(3):338-46. PubMed ID: 25108027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
    Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
    JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.
    Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM
    Front Immunol; 2019; 10():2307. PubMed ID: 31649662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants.
    Garcia-Knight MA; Nduati E; Hassan AS; Gambo F; Odera D; Etyang TJ; Hajj NJ; Berkley JA; Urban BC; Rowland-Jones SL
    PLoS One; 2015; 10(11):e0143043. PubMed ID: 26569505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
    Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
    AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M;
    Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Hesseling AC; Jaspan HB; Black GF; Nene N; Walzl G
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):454-62. PubMed ID: 25860002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.
    Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Immunodeficiency Virus Exposure but Not Early Cytomegalovirus Infection Is Associated With Increased Hospitalization and Decreased Memory T-Cell Responses to Tetanus Vaccine.
    Smith C; Moraka NO; Ibrahim M; Moyo S; Mayondi G; Kammerer B; Leidner J; Gaseitsiwe S; Li S; Shapiro R; Lockman S; Weinberg A
    J Infect Dis; 2020 Mar; 221(7):1167-1175. PubMed ID: 31711179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.
    Mansoor N; Scriba TJ; de Kock M; Tameris M; Abel B; Keyser A; Little F; Soares A; Gelderbloem S; Mlenjeni S; Denation L; Hawkridge A; Boom WH; Kaplan G; Hussey GD; Hanekom WA
    J Infect Dis; 2009 Apr; 199(7):982-90. PubMed ID: 19236280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia.
    Ritz N; Casalaz D; Donath S; Tebruegge M; Dutta B; Connell TG; Robins-Browne R; Britton WJ; Hanekom WA; Curtis N
    Vaccine; 2016 Jul; 34(35):4132-4139. PubMed ID: 27396518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.
    Kagina BM; Abel B; Bowmaker M; Scriba TJ; Gelderbloem S; Smit E; Erasmus M; Nene N; Walzl G; Black G; Hussey GD; Hesseling AC; Hanekom WA
    Vaccine; 2009 Sep; 27(40):5488-95. PubMed ID: 19616494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.
    Geldenhuys HD; Mearns H; Foster J; Saxon E; Kagina B; Saganic L; Jarrahian C; Tameris MD; Dintwe OB; Van Rooyen M; Luabeya KK; Hussey G; Scriba TJ; Hatherill M; Zehrung D
    Vaccine; 2015 Sep; 33(37):4719-26. PubMed ID: 25862299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants.
    Lutwama F; Kagina BM; Wajja A; Waiswa F; Mansoor N; Kirimunda S; Hughes EJ; Kiwanuka N; Joloba ML; Musoke P; Scriba TJ; Mayanja-Kizza H; Day CL; Hanekom WA
    J Infect Dis; 2014 Mar; 209(6):887-97. PubMed ID: 24179111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines.
    Vermeulen F; Verscheure V; Damis E; Vermeylen D; Leloux G; Dirix V; Locht C; Mascart F
    Clin Vaccine Immunol; 2010 Feb; 17(2):258-62. PubMed ID: 20016042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.